In This Section

Newsroom

October 16, 2019
Temple Awarded 5-year, $3.27 Million NIH Grant to Investigate Inflammation Associated with HIV Infection in the Context of Opioid Addiction

Research will focus on why HIV infection in the brain leads to greater sensitivity to pain and reduced effectiveness of opioid therapeutics.
- VIEW STORY
October 15, 2019
Katz School of Medicine, Temple Health Donors Ignite the Spirit of Giving in Fiscal Year 2019

Alumni, friends, patients and employees made significant gifts to Temple Health during fiscal year 2019, raising $32 million in support of education, patient care, research and service to the community.
- VIEW STORY
October 08, 2019
Temple Researchers Map Key Signaling Pathways Linking Calcium Entry and Exit in Activated T Cells

The study offers new insight into calcium signaling that could help scientists better understand the signaling mechanisms underlying autoimmune and immunodeficiency diseases, many of which involve abnormal T-cell activation.
- VIEW STORY
October 04, 2019
Temple Scientists Identify New Targets to Treat Fibrosis – a Feature of Many Chronic Diseases

In new work, Lewis Katz School of Medicine at Temple University researchers show how fibroblast activation and myofibroblast formation occurs, providing clues as to how to target fibrosis, which impacts several chronic diseases.
- VIEW STORY
October 02, 2019
Physician Assistant Students Don First White Coats

On September 20, students gathered for their White Coat Ceremony in Temple’s Erny Auditorium. The ceremony signifies the beginning of a student’s journey to becoming a full-fledged medical professional, while the white coat symbolizes professionalism, caring and trust.
- VIEW STORY
September 30, 2019
New Analyses of Two International Clinical Trials Predict Response to Asthma Drug Benralizumab by Subpopulation of Patients with COPD

Results from two Phase III, international clinical trials named GALATHEA and TERRANOVA showed that the asthma drug benralizumab failed to decrease annual COPD exacerbation rates for patients with moderate to very severe COPD, a history of frequent moderate and/or severe exacerbations, and eosinophilic inflammation.
- VIEW STORY
September 25, 2019
Temple Scientists Solve Mystery Underlying Heart Toxicity Caused By Diabetes Drugs

In new research published in the journal JCI Insight, scientists at the Lewis Katz School of Medicine at Temple University show for the first time that dual PPARα/γ diabetes drugs have a profound toxic effect on the generation and function of mitochondria, the tiny energy factories that power cells.
- VIEW STORY
September 20, 2019
Sponge-Like Action of Circular RNA Aids Heart Attack Recovery, Temple-Led Research Team Discovers

Circular RNAs, like other noncoding RNAs, were thought to be nonfunctional, but recent evidence suggests otherwise. Circular RNAs may in fact act like sponges to “soak up,” or bind, other molecules, including microRNAs and proteins, and now, new work by researchers at the Lewis Katz School of Medicine at Temple University and colleagues supports this idea.
- VIEW STORY

Newsroom

Pages